123 related articles for article (PubMed ID: 19192887)
21. Kinetic and mechanistic considerations in the gelation of genipin-crosslinked gelatin.
Nickerson MT; Patel J; Heyd DV; Rousseau D; Paulson AT
Int J Biol Macromol; 2006 Nov; 39(4-5):298-302. PubMed ID: 16797690
[TBL] [Abstract][Full Text] [Related]
22. Effect of sterilization and crosslinking on gelatin films.
Amadori S; Torricelli P; Rubini K; Fini M; Panzavolta S; Bigi A
J Mater Sci Mater Med; 2015 Feb; 26(2):69. PubMed ID: 25631265
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of gelatin scaffolds crosslinked by genipin and silane coupling agent.
Tonda-Turo C; Gentile P; Saracino S; Chiono V; Nandagiri VK; Muzio G; Canuto RA; Ciardelli G
Int J Biol Macromol; 2011 Nov; 49(4):700-6. PubMed ID: 21767562
[TBL] [Abstract][Full Text] [Related]
24. Genipin-crosslinked microcarriers mediating hepatocellular aggregates formation and functionalities.
Lau TT; Wang C; Png SW; Su K; Wang DA
J Biomed Mater Res A; 2011 Jan; 96(1):204-11. PubMed ID: 21105169
[TBL] [Abstract][Full Text] [Related]
25. Controlled release of DSBP from genipin-crosslinked gelatin thin films.
Abbasi A; Eslamian M; Heyd D; Rousseau D
Pharm Dev Technol; 2008; 13(6):549-57. PubMed ID: 18720250
[TBL] [Abstract][Full Text] [Related]
26. Induction of angiogenesis using VEGF releasing genipin-crosslinked electrospun gelatin mats.
Del Gaudio C; Baiguera S; Boieri M; Mazzanti B; Ribatti D; Bianco A; Macchiarini P
Biomaterials; 2013 Oct; 34(31):7754-65. PubMed ID: 23863451
[TBL] [Abstract][Full Text] [Related]
27. The micro patterning of glutaraldehyde (GA)-crosslinked gelatin and its application to cell-culture.
Yang LJ; Ou YC
Lab Chip; 2005 Sep; 5(9):979-84. PubMed ID: 16100583
[TBL] [Abstract][Full Text] [Related]
28. Preparation of PLGA scaffolds with graded pores by using a gelatin-microsphere template as porogen.
Tang G; Zhang H; Zhao Y; Zhang Y; Li X; Yuan X
J Biomater Sci Polym Ed; 2012; 23(17):2241-57. PubMed ID: 22137329
[TBL] [Abstract][Full Text] [Related]
29. Delivery of basic fibroblast growth factor from gelatin microsphere scaffold for the growth of human umbilical vein endothelial cells.
Zhu XH; Tabata Y; Wang CH; Tong YW
Tissue Eng Part A; 2008 Dec; 14(12):1939-47. PubMed ID: 18636948
[TBL] [Abstract][Full Text] [Related]
30. Microencapsulation of Zanthoxylum limonella oil (ZLO) in glutaraldehyde crosslinked gelatin for mosquito repellent application.
Maji TK; Baruah I; Dube S; Hussain MR
Bioresour Technol; 2007 Mar; 98(4):840-4. PubMed ID: 16697181
[TBL] [Abstract][Full Text] [Related]
31. Gelatin methacrylate microspheres for controlled growth factor release.
Nguyen AH; McKinney J; Miller T; Bongiorno T; McDevitt TC
Acta Biomater; 2015 Feb; 13():101-10. PubMed ID: 25463489
[TBL] [Abstract][Full Text] [Related]
32. Biocompatibility and biodegradation of a bone composite containing tricalcium phosphate and genipin crosslinked gelatin.
Yao CH; Liu BS; Hsu SH; Chen YS; Tsai CC
J Biomed Mater Res A; 2004 Jun; 69(4):709-17. PubMed ID: 15162413
[TBL] [Abstract][Full Text] [Related]
33. Genipin blues: an alternative non-toxic crosslinker for heart valves?
Somers P; De Somer F; Cornelissen M; Bouchez S; Gasthuys F; Narine K; Cox E; Van Nooten G
J Heart Valve Dis; 2008 Nov; 17(6):682-8. PubMed ID: 19137802
[TBL] [Abstract][Full Text] [Related]
34. Effects of nerve growth factor from genipin-crosslinked gelatin in polycaprolactone conduit on peripheral nerve regeneration--in vitro and in vivo.
Chang CJ
J Biomed Mater Res A; 2009 Nov; 91(2):586-96. PubMed ID: 18985781
[TBL] [Abstract][Full Text] [Related]
35. The effect of procyanidine crosslinking on the properties of the electrospun gelatin membranes.
Chen Z; Wang L; Jiang H
Biofabrication; 2012 Sep; 4(3):035007. PubMed ID: 22917934
[TBL] [Abstract][Full Text] [Related]
36. Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres.
Forni F; Vandelli MA; Cameroni R
J Microencapsul; 1992; 9(1):29-39. PubMed ID: 1613641
[TBL] [Abstract][Full Text] [Related]
37. Gelatin microspheres crosslinked with D,L-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies.
Vandelli MA; Rivasi F; Guerra P; Forni F; Arletti R
Int J Pharm; 2001 Mar; 215(1-2):175-84. PubMed ID: 11250103
[TBL] [Abstract][Full Text] [Related]
38. Development of gelatin microspheres loaded with diclofenac sodium for intra-articular administration.
Saravanan M; Bhaskar K; Maharajan G; Pillai KS
J Drug Target; 2011 Feb; 19(2):96-103. PubMed ID: 20380621
[TBL] [Abstract][Full Text] [Related]
39. Osteogenic evaluation of glutaraldehyde crosslinked gelatin composite with fetal rat calvarial culture model.
Liu HC; Yao CH; Sun JS; Lee CJ; Huang CW; Lin FH
Artif Organs; 2001 Aug; 25(8):644-54. PubMed ID: 11531717
[TBL] [Abstract][Full Text] [Related]
40. In vitro evaluation of degradation and cytotoxicity of a novel composite as a bone substitute.
Liu BS; Yao CH; Chen YS; Hsu SH
J Biomed Mater Res A; 2003 Dec; 67(4):1163-9. PubMed ID: 14624502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
